“Some will reach our shores through the black and grey market, outside the safeguards on quality, storage, prescribing and monitoring. The piecemeal and unequal access to weight-loss medicines on the NHS risks compounding the problem, as most eligible patients today have no choice but to pay for private treatment.”
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
